Clinical Trial Update: Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating sodium valproate for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Sodium valproate (valproate)

Snippet

Sponsor: UMC Utrecht | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED